bullish
Treakisym to Be Used as a Pre-Treatment To CAR-T Therapy
732 Views28 Sep 2018 20:14
Announcement – Symbio Pharmaceuticals (4582 JP) on September 27, 2018, announced that it has filed a partial change application for marketing...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Symbio Confirms Treakisym’s In-House Commercialization Post Patent Expiration in 2020e16 Oct 2018
- Treakisym to Be Used as a Pre-Treatment To CAR-T Therapy28 Sep 2018
x